Yahoo!
My Yahoo!
Mail
Sign In
[New User?
Sign Up
]
Finance Home
|
Help
Wednesday, February 10, 2010, 6:12am EST - Canadian Markets open in 3 hours and 18 minutes.
To create a watchlist or portfolio of shares,
Sign-in
or
Register
Finance Home
Investing
Volume Leaders
Local Markets
US Markets
International Markets
Advances & Declines
ETFs
Income Trust News
News & Opinion
Markets
Industry
RSS-My Yahoo!
Personal Finance
Banking & Budgeting
Calculators
Insurance
Retirement
Taxes
My Portfolios
Sign In to Create/Edit My Portfolios
Get Quotes
Symbol Lookup
Exchanges
Amgen Inc. (AMGN)
On Feb 9:
57.21 USD
0.00 (0.00%)
MORE ON AMGN
Quotes
Summary
Options
Historical Prices
Charts
Interactive
Basic Chart
Technical Chart
News & Info
Headlines
Company Events
Company
Profile
Key Statistics
SEC Filings
Competitors
Industry
Analyst Coverage
Analyst Opinion
Analyst Estimates
Research Reports
Star Analysts
Ownership
Major Holders
Insider Trans.
Insider Roster
Financials
Income Statement
Balance Sheets
Cash Flow
Headlines
Get
Headlines
for:
Tue, Feb 9, 2010
U.S. Stocks Gain on Hopes for Greece Aid
at The Wall Street Journal Online
(Tue 10:09pm)
Amgen's denosumab offers hope in rare bone tumours
at Reuters
(Tue 7:01pm)
Coca-Cola and industrials help stocks rally
at FT.com
(Tue 5:20pm)
Amgen, Apple: Money Flow Leaders (AMGN, AAPL)
at The Wall Street Journal Online
(Tue 4:25pm)
Dow Over 10,000; Greek Rescue Plan Pondered
at SmartMoney.com
(Tue 3:17pm)
Don't Invest Another Penny
at Motley Fool
(Tue 12:41pm)
Bone Up On This Potential Blockbuster
at Motley Fool
(Tue 11:58am)
Amgen sees positive data in bone drug study
AP
(Tue 10:58am)
Positive Results on Amgen Drug
Zacks.com
(Tue 10:49am)
Indications: U.S. futures recover after sub-10,000 Dow close
at MarketWatch
(Tue 8:59am)
Mon, Feb 8, 2010
UPDATE - Amgen: denosumab prostate cancer trial meets goals
at Reuters
(Mon, Feb 8)
Denosumab Demonstrated Superiority Over Zometa(R) in Pivotal Phase 3 Head-to-Head Trial in Prostate Cancer Patients With Bone Metastases
PRNewswire
(Mon, Feb 8)
[$$] Biotech ETFs Are Looking Healthy
at RealMoney by TheStreet.com
(Mon, Feb 8)
UPDATE - Qiagen profit beats estimate on demand for tests
at Reuters
(Mon, Feb 8)
Correction is Healthy - and a Buying Opportunity: Strategist
at CNBC
(Mon, Feb 8)
4 Winning Biotechs For Your Portfolio: Senior Analyst
at CNBC
(Mon, Feb 8)
Is Biotech Back?
CNBC
(Mon, Feb 8)
[video] Is Biotech Back?
at CNBC
(Mon, Feb 8)
Sat, Feb 6, 2010
Note to Dell, Google and All: It's Time to Pay the Owners
at The Wall Street Journal Online
(Sat, Feb 6)
[video] 3 Great American Stocks
at TheStreet.com
(Sat, Feb 6)
Older Headlines
View headlines from:
Sat, Feb 6, 2010
Sat, Jan 30, 2010
Sat, Jan 23, 2010
Sat, Jan 16, 2010
Sat, Jan 9, 2010
Sat, Jan 2, 2010
Sat, Dec 26, 2009
Sat, Dec 19, 2009
Sat, Dec 12, 2009
Sat, Dec 5, 2009
Add to Portfolio
Email to a Friend
Get
Headlines
for Another Symbol:
Symbol Lookup
Latest News
Canadian Indices